首页> 外文期刊>Inflammation >Potential Effects of Calcium Binding Protein S100A12 on Severity Evaluation and Curative Effect of Severe Acute Pancreatitis
【24h】

Potential Effects of Calcium Binding Protein S100A12 on Severity Evaluation and Curative Effect of Severe Acute Pancreatitis

机译:钙结合蛋白S100A12对严重急性胰腺炎严重程度评估和疗效的潜在作用

获取原文
获取原文并翻译 | 示例
           

摘要

Severe acute pancreatitis is a life threatening disease with a high rate of mortality, but its treatments are still controversial. The purpose of this study is to investigate the potential effects of calcium binding protein S100A12 on severity evaluation and curative effect of severe acute pancreatitis induced by caerulein and lipopolysaccharide in mice. Intraperitoneal injection of 50 mu g/kg caerulein for seven times (every interval time was an hour) and intraperitoneal injection of 10 mg/kg lipopolysaccharide for once to establish acute pancreatitis mice models. One hundred sixty specific pathogen-free imprinting control region (ICR) female mice were randomly divided into the control group (group A, normal saline), the mild group (group B, caerulein), the severe group (group C, caerulein + lipopolysaccharide), and the intervention group (group D, S100A12 recombinant antibodies + caerulein + lipopolysaccharide); each group had 40 mice. We sampled the blood at 8, 12, and 24 h after the beginning of building animal models. In each period of time, we respectively detected the serum S100A12, amylase (AMY), C-reactive protein (CRP), interleukin (IL-1 beta, IL-6), and tumor necrosis factor (TNF-alpha) levels. In addition, we observed and scored the pancreas and lungs histopathology of the mice. In each same period of time compared with group C, serum AMY, CRP, IL-1 beta, IL-6, TNF-alpha levels of group D were significantly decreased (p < 0.05). In each same period of time compared with group B and group C, serum S100A12 concentration of group D was significantly decreased (p < 0.05), and the pancreas and lungs histopathology were also much improved. These observations demonstrate that S100A12 recombinant antibodies were able to significantly reduce the severity of acute pancreatitis induced by caerulein and lipopolysaccharide in mice. Serum S100A12 may serve as a useful marker for disease severity and curative effect in mice with severe acute pancreatitis.
机译:重症急性胰腺炎是一种威胁生命的疾病,死亡率很高,但其治疗方法仍存在争议。这项研究的目的是研究钙结合蛋白S100A12对轻度考林素和脂多糖诱导的小鼠急性重症急性胰腺炎的严重程度评估和疗效的潜在影响。腹膜内注射50μg / kg芥蓝素7次(每次间隔一个小时),腹膜内注射10 mg / kg脂多糖一次以建立急性胰腺炎小鼠模型。将160只无病原体的特定印记控制区(ICR)雌性小鼠随机分为对照组(A组,生理盐水),轻度组(B组,铜绿素),重度组(C组,铜绿素+脂多糖) ),以及干预组(D组,S100A12重组抗体+ caerulein +脂多糖);每组有40只小鼠。在开始建立动物模型后的8、12和24小时,我们对血液进行了采样。在每个时间段,我们分别检测血清S100A12,淀粉酶(AMY),C反应蛋白(CRP),白介素(IL-1 beta,IL-6)和肿瘤坏死因子(TNF-alpha)水平。另外,我们观察并评分了小鼠的胰腺和肺的组织病理学。与C组相比,在同一时间段,D组的血清AMY,CRP,IL-1β,IL-6和TNF-α水平均显着降低(p <0.05)。在同一时间段内,与B组和C组相比,D组的血清S100A12浓度显着降低(p <0.05),胰腺和肺的组织病理学也得到了很大改善。这些观察结果表明,S100A12重组抗体能够显着降低小鼠中的轻油蛋白和脂多糖诱导的急性胰腺炎的严重程度。血清S100A12可用作严重急性胰腺炎小鼠疾病严重程度和疗效的有用标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号